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Abstract 
Objective: Adherence to Continuous Positive Airway Pressure Therapy (CPAP) for Obstructive 
Sleep Apnoea (OSA) is poor. We assessed the effectiveness of a motivational interviewing 
intervention (MINT) in addition to best practice standard care to improve acceptance and adherence 
to CPAP therapy in people with a new diagnosis of OSA.  
Method: 106 Australian adults (69% male) with a new diagnosis of obstructive sleep apnoea and 
clinical recommendation for CPAP treatment were recruited from a tertiary sleep disorders centre. 
Participants were randomly assigned to receive either three sessions of a motivational interviewing 
intervention ‘MINT’ (n=53; mean age=55.4 years), or no intervention ‘Control’ (n=53; mean 
age=57.74).  The primary outcome was the difference between the groups in objective CPAP 
adherence at 1 month, 2 months, 3 months and 12 months follow-up. 
Results: Fifty (94%) participants in the MINT group and 50 (94%) of participants in the control 
group met all inclusion and exclusion criteria and were included in the primary analysis. The hours 
of CPAP use per night in the MINT group at 3 months was 4.63 hours and 3.16 hours in the control 
group (p=0.005). This represents almost 50% better adherence in the MINT group relative to the 
control group. Patients in the MINT group were substantially more likely to accept CPAP treatment. 
Conclusions: MINT is a brief, manualized, effective intervention which improves CPAP acceptance 
and objective adherence rates as compared to standard care alone. 
Motivational Intervention improves CPAP adherence 
 3
Obstructive Sleep Apnoea (OSA) is a common sleep disorder, internationally affecting 
about 5% of the population (Access Economics, October 2004; American Academy of Sleep 
Medicine, 1999, 2005; Malhotra & White, 2002; Olson, King, Hensley, & Saunders, 1995; Young, 
Peppard, & Gottlieb, 2002) although the five year incidence of sleep disordered breathing may be 
two to three times this in urban adult populations in the US (Tishler, Larkin, Schluchter, & Redline, 
2003).  OSA is associated with high economic and social costs (Wittman & Rodenstein, 2004). 
The two main clinical features of OSA are respiratory disturbances, and the arousals from 
sleep that are needed to reinstate breathing. These two features lead to the two main clinical 
consequences of the disorder, hypoxia of the brain and heart, and sleep fragmentation. Daytime 
sleepiness and hypoxia of the brain are associated with cognitive deficits, such as impaired working 
memory, attention and psychomotor problems (Aloia et al., 2003; Gale & Hopkins, 2004; Yaouhi et 
al., 2009). Hypoxia of the heart increases the risk of heart-related diseases, such as hypertension 
(American Academy of Sleep Medicine, 2005; Coughlin, Mawdsley, Mugarza, Wilding, & 
Calverley, 2007; Jordan et al., 2005; Malhotra & White, 2002). Patients with OSA are also at higher 
risk for Type II diabetes and stroke (Guest, Helter, Morga, & Stradling, 2008; Malhotra & White, 
2002; The Boston Consulting Group, 2003). 
OSA patients are often chronically sleep deprived due to the constant brief arousals needed 
to reinstate breathing (Al-Barrak, Shepertycky, & Kryger, 2003; Chervin, 2000). The effects of 
sleepiness and impaired concentration are most obvious in the increased risk of a car accident 
(odds-ratio of 7.3) over five years for individuals with OSA, compared to individuals of similar 
demographic status without OSA (Young, et al., 2002). Even relatively mild symptoms of OSA are 
associated with lower self-reported general health status. This is even the case when considered 
independently of age, sex, weight and body mass index (BMI), tobacco use, alcohol use, and history 
of cardiovascular disease (Finn, Young, Palta, & Fryback, 1998). 
Lifestyle modification and behavioural interventions are often implemented in the treatment 
of OSA, and may be the preferred treatment in mild OSA (Tuomilehto et al., 2009). Among the 
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most common forms of treatment for OSA is the use of mandibular enhancement splint (Ferguson, 
Ono, Lowe, Keenan, & Fleetham, 1996; Pancer, Al-Faifi, Al-Faifi, & Hoffstein, 1999; Perlis & 
Lichstein, 2003). This treatment involves the fitting of a mouth piece. Mandibular enhancement 
may be up to 80% effective in reducing snoring in mild to moderate OSA (Perlis & Lichstein, 
2003), but is only 30% to 50% effective in producing a clinically significant reduction in the 
respiratory disturbances which characterise OSA (Aarab, Lobbezoo, Wicks, Hamburger, & Naeije, 
2005; Ferguson, et al., 1996; Perlis & Lichstein, 2003). 
The cost-effectiveness of treating OSA with Continuous Positive Airway Pressure (CPAP) 
therapy has been demonstrated (Access Economics, October 2004; Wittman & Rodenstein, 2004), 
with CPAP being the current ‘gold standard’ and most effective treatment for moderate to severe 
OSA (Kushida et al., 2005; Malhotra, Ayas, & Epstein, 2000; Stepnowsky & Moore, 2003). In this 
therapy, pressurised air is administered through a nasal or full face mask, preventing the upper 
airway from collapse (Kushida, et al., 2005; Malhotra, et al., 2000; Stepnowsky & Moore, 2003). 
Use of CPAP every night, right throughout the night, is required to prevent the return of obstructive 
respiratory events (Malhotra, et al., 2000). 
The economic cost of CPAP treated OSA is much less than the economic burden caused by 
untreated OSA (Access Economics, October 2004; Kushida, et al., 2005). Treated OSA, including 
treatment expense and follow-up, incurs approximately half the long term health care cost of 
undiagnosed and untreated patients (Wittman & Rodenstein, 2004). A recent economic 
effectiveness study of CPAP in the British health context identified that, over a 14 year period, an 
individual with severe OSA who is successfully treated with CPAP is likely to have a 25% greater 
chance of survival. Moreover, they are at 46% decreased risk of cardiovascular events, 49% 
reduced risk of stroke, have 31% less chance of experiencing road traffic accidents, and overall 
have a 92% increased probability of event-free survival (Guest, et al., 2008). 
Despite the potential positive health, lifestyle and general wellbeing benefits from treatment 
of OSA with CPAP therapy (Wittman & Rodenstein, 2004)  the effectiveness of the therapy is 
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severely limited by suboptimal adherence. Up to 30% of patients do not accept CPAP treatment 
from the outset (i.e. they never ‘start’ on the treatment) (Guest, et al., 2008). Of those patients who 
do initially accept CPAP, up to 50% fail to adhere optimally. That is, they do not use it at the 
prescribed pressure, or do not use it for long during sleep (Collard, Pieters, Aubert, Delguste, & 
Rodenstein, 1997; Fletcher & Luckett, 1991).  
There is now strong evidence that individual psychological factors, over and above 
biomedical factors associated with the treatment, explain a significant degree of the variance in 
CPAP acceptance and adherence (Zozula & Rosen, 2001). There is also evidence for the addition of 
psychological-based interventions to improve CPAP adherence when compared to standard care 
alone (Olsen, Smith, & Oei, 2008) or to time-matched placebo (Aloia et al., 2001; Richards, 
Bartlett, Wong, Malouff, & Grunstein, 2007).  Large effect sizes for an increase in hours of use of 
CPAP each night have been suggested by these studies (Cohen’s d=1.09-1.27) (Aloia, Smith, 
Arnedt, Millman, Stanchina, & Carlisle, 2007), however interpretation of these data is limited by 
low sample size (I. Smith, Nadig, & Lasserson, 2009), short-term follow up, uncertain treatment 
components or inadequate trials reporting (see Olsen, Smith, & Oei, 2008 for a review).  
In previous work, we have presented a theoretical Health Belief model (HBM) of CPAP 
adherence (Olsen, Smith, & Oei, 2008; Olsen, Smith, Oei, & Douglas, 2008), as have others 
(Tyrrell, Poulet, Pepin, & Veale, 2006). The health beliefs reported by patients before they have 
experienced CPAP can predict early patterns of CPAP use and longer-term objective adherence to 
the treatment.  Specifically, health beliefs such as perception of severity (as it pertains to the impact 
of OSA on important daily activities, such as intimate relationships, general productivity), 
perception of benefits of CPAP use, and perception of the risk of negative health consequences 
associated with untreated OSA, predicted greater than 30% of the variance in CPAP adherence four 
months down the track. Consistent with this are findings that early CPAP acceptance (Olsen, Smith, 
Oei, et al., 2008) is a critical determinant of continued use (Aloia, Arnedt, Stanchina, & Millman, 
2007; Aloia, Arnedt, Stepnowsky, Hecht, & Borrelli, 2005; Means et al., 2003; Weaver, Kribbs, et 
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al., 1997).  These findings suggests that patients have developed beliefs and expectations regarding 
CPAP before they have even tried the treatment, and this presents an opportunity for an early 
intervention to modify these beliefs and improve adherence.  
On the basis of our previous work with the HBM, and the review of the CPAP adherence 
intervention literature (see Olsen, Smith, & Oei, 2008 for a review), we developed a CPAP-specific 
Motivational Interview Nurse Therapy (MINT) intervention designed to target the motivational 
factors associated with poor CPAP uptake and adherence in OSA sufferers. Motivational 
Interviewing is a particularly relevant intervention for the problem of CPAP adherence in OSA 
(Aloia, Arnedt, et al., 2007; Weaver & Grunstein, 2008) as it addresses the patient’s ambivalence 
regarding CPAP use, and is consistent with several of the models of behaviour change which have 
been applied to CPAP, including HBM (Aloia, Arnedt, Riggs, Hecht, & Borrelli, 2004).  
Motivational Interviewing-based interventions have gained recognition as effective for 
increasing healthy behaviours and for reducing unhealthy behaviours. Motivational interventions 
generally demonstrate the best outcomes when targeting treatment adherence and engagement in 
healthy behaviours (such as diet and exercise plans), rather than for interventions targeting the 
reduction of unhealthy behaviours (such as smoking and alcohol dependence) (Burke, Arkowitz, & 
Menchola, 2003). Such interventions have been shown to improve patient adherence to prescription 
drug regimes, diet and exercise programs, and improve attendance at outpatient treatment clinics 
(Britt, Hudson, & Blampied, 2004). Furthermore, it can be effective over just a few sessions, 
particularly when delivered according to a manualised protocol (Burke, et al., 2003). The explicit 
mechanism of change due to motivational interviewing lies in increasing patients’ positive 
expectations for change (benefits) and shifting the balance of patients’ focus from the barriers to the 
benefits of treatment (Hettema, Steele, & Miller, 2005).   
Our MINT intervention directly and explicitly targets the modifiable components of the 
HBM for CPAP adherence. Specifically, MINT focuses on addressing the patient’s ambivalence 
and resistance to change, as expressed by their belief that the treatment is not effective (benefits), 
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that they do not have a significant problem (perceived severity), and that they are not susceptible to 
negative health consequences if they do not use CPAP (perceived risk). Moreover, MINT targets 
the patient’s perception that the treatment is too difficult to use and the side effects are too severe, 
and that they do not have the ability to use the treatment (self-efficacy) in the face of these 
difficulties (Hettema, et al., 2005; Prochaska & DiClemente, 1982). MINT targets these perceptions 
using four general principles that guide the delivery of the therapy. These principles include: 
expressing empathy, developing discrepancy, rolling with resistance and supporting self-efficacy. 
Helping a patient to develop specific goals for CPAP use, and building their self-efficacy, are two 
intervention strategies with some existing empirical support (Olsen, Smith, & Oei, 2008). 
Our aim was to estimate the effectiveness of the MINT intervention, designed to target 
health beliefs and perceptions associated with poor CPAP adherence, in newly diagnosed OSA 
patients, newly prescribed CPAP treatment. Our primary hypothesis was that CPAP acceptance and 
adherence would be higher in participants randomly assigned to the MINT intervention as 
compared to participants assigned to control, and that this difference would be maintained out to 12 
months follow up. 
 
Methods 
 
Participants 
The MINT trial was a pragmatic, single centre randomized control trial. Participants were 
invited into this study by their treating sleep physician following their overnight diagnostic study 
(the study required to diagnose OSA).  Participants were eligible for inclusion if they were at least 
18 years old, had a diagnosis of OSA confirmed by clinical polysomnography (PSG), had a clinical 
recommendation for CPAP treatment, and were naive to CPAP treatment. Participants were 
excluded from the study if they were found to require bi-level ventilation (e.g. due to evidence of 
Central Sleep Apnoea Syndrome), did not complete a CPAP titration study, or were unable to give 
informed consent. Of the total number of participants meeting inclusion criteria that were invited 
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into the study between May 2007 and December 2008 (n=129), 23 declined to participate (18%). 
Primary reported reasons for declining to participate included time constraints; living outside of 
health district; “I don’t think I need it” (I already want to succeed with CPAP). No other 
demographic data of individuals declining to participate is available. 
The Human Research Ethics Committees of the University of Queensland and the Prince 
Charles Hospital Health Services District approved the trial protocol (HREC2004000258 & 
EC2609, respectively). All participants gave informed consent to participate. Participants received 
no financial incentive to participate. Participants in the MINT group received compensation in the 
form of a parking voucher for attending intervention sessions that were outside of usual clinic 
contact.  
Randomization and masking 
Eligible participants were randomly assigned to receive standard care alone (control) or 
standard care plus MINT.  An equal number of allocations for the control (n=53) and MINT groups 
(n=53) were placed into opaque, unlabelled envelopes, and the envelopes shuffled by a research 
assistant. No blocking or stratification of randomization was used.  The envelopes were then placed 
into an allocation box held in a secure clinic area.  After recruitment into the study, participants 
were directed to the Sleep Centre’s Administrative Officers in order to schedule future 
appointments. The officer withdrew an envelope containing the intervention allocation and booked 
the patient’s future appointments on that basis. The Administrative Officers were not otherwise 
involved in recruitment or provision of the intervention. The nature of the intervention meant that 
we were unable to mask either the participants or the intervention nurses to treatment assignment.   
 
Procedures 
After allocation, participants were booked for a CPAP titration study with an additional 
MINT session on the day of the study if they were allocated to the MINT group. Participants were 
requested to complete the baseline (Time 1) questionnaire and bring this in to the CPAP titration 
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study day (the overnight study used to determine the therapeutic level of CPAP pressure required to 
reduce respiratory disturbances below five events per hour).  Participants presented to the Sleep 
Disorders Centre for their CPAP titration study approximately one month after recruitment. 
Participants had completed their first questionnaire before the CPAP education session. On the 
CPAP titration day, participants completed a standard 45 minute education session and also the first 
MINT session (if in the MINT group).   
After the overnight titration study, participants attended the Sleep Centre approximately two 
to four weeks later to receive the results and medical advice regarding their titration study from 
their Sleep Physician, and to be given their prescription for CPAP based on the therapeutic CPAP 
pressure derived from the titration study. Participants in the MINT group received the second MINT 
session at this time point.  
All participants were provided with the second questionnaire one-month after the titration 
study results appointment with their Sleep Physician. The questionnaire consisted of the outcome 
measures, questions about any difficulties they were having with CPAP, and a request for the meter 
reading on the CPAP machine (from the on-board counter on the machine which keeps track of the 
number of hours the patient has been using the machine) if they had commenced on CPAP. 
Participants in the control group received a brief telephone call from a nurse, who was not trained in 
MINT, to assist them to locate the meter reading on their machine. Nurses were instructed to keep 
this phone call extremely brief and restricted to obtaining the meter reading on the machine. Instead 
of this phone call, participants in the MINT group were asked to attend the Sleep Centre for the 
MINT Booster Session. Meter readings were obtained from the participant’s machine if they had 
commenced CPAP by this time. The one month questionnaire was also completed after the Booster 
Session. If participants had forgotten to bring the CPAP machine to the session, they were called 
within a few days by a nurse to collect this information. Participants living in rural and remote 
Queensland received the booster session by telephone.  
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One month after this (at the two-month follow-up point), participants were requested to 
attend a standard nurse clinic where technical issues were discussed and a standard meter download 
was obtained (by telephone for rural and remote participants). One month later (three months 
follow-up) all participants were sent a questionnaire containing a reply paid envelope. The 
questionnaire consisted of outcome measures, questions about any difficulties with CPAP, and a 
request for the meter reading on the CPAP machine if they had commenced on CPAP. Participants 
received a brief phone call to assist with the meter download. Finally participants were contacted at 
12 months follow-up for a meter download. Figure 1 provides a visual timeline for the MINT and 
control groups. 
Figure 1 Here 
  
MINT Intervention 
 
The MINT intervention is fully standardised and manualized, delivered in an individual 
format, with the content for each session stipulated.  The manual was initially informed by the 
Motivational Enhancement Therapy Manual developed by Miller and colleagues (Miller, Zweben, 
DiClemente, & Rychtarik, 1995) but with significant modification to increase the relevance to the 
OSA population (Aloia, et al., 2004). Table 1 outlines the targeted session content. Personalised 
feedback was a key component of session one. As well as receiving general feedback about OSA 
severity, patients were provided feedback on their own responses to a satisfaction with life scale 
(not reported here) and perception of functional severity (FOSQ) questionnaire completed at 
baseline. Specifically, the domains of the FOSQ, as well as general health information, such as 
BMI, age, cardiovascular comorbidities, and level of ‘snoring’ observed in the sleep study were 
discussed.  
Three studies have investigated the impact of Cognitive-Behaviour and Motivational 
Interviewing orientated interventions on CPAP adherence, and compared these to standard care   
(Aloia, et al., 2001; Richards, et al., 2007) or to time-matched placebo (Aloia, Smith, Arnedt, 
Millman, Stanchina, Carlisle, et al., 2007). This is the first intervention of its kind to incorporate 
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and test HBM theory through a motivational interviewing-based treatment with an OSA population.  
Sessions one and two were approximately 30 minutes in duration (maximum 45 minutes) and the 
Booster session was approximately 20 minutes in length (maximum 30 minutes).  
Table 1 Here 
 
Participants were encouraged to bring along a significant other to the two initial MINT 
sessions. 21 participants (42%) had a significant other who attended at least one MINT session. 
 
Nurse Training 
Three nurses with 2-16 years specific sleep medicine training delivered the intervention. The 
nurses underwent a full-day training session with a registered Psychologist trained in clinical, 
health, sleep and neuropsychology (author SO). The nurse training session was a structured protocol 
based on the manual used for this intervention. The training day was video recorded. Regular 
supervision sessions were conducted between the nurses and the trainer following the training day.  
 
Control 
 
All participants underwent standard care, which consisted of a one-on-one 45 minute 
education session conducted on the day of the CPAP titration study. The details of this education 
session have already been described elsewhere (Olsen, Smith, Oei, et al., 2008; S. Smith, Lang, 
Sullivan, & Warren, 2004). Briefly, nursing staff presented the participant with their diagnostic 
polysomnography (PSG) results, discussed how the CPAP machine worked and talked about 
common experiences that participants have during the titration study. Participants were also fitted 
with an appropriate mask for use during the titration study, and were given approximately 10 
minutes to try the mask with pressure delivered. In addition to the education session, participants 
completed a questionnaire assessing CPAP related difficulties one month after CPAP experience. 
One month later (two months after CPAP experience) participants attended a standard nurse clinic 
where meter readings were obtained, and difficulties with CPAP use were discussed and addressed.   
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Measures 
Data were collected at baseline, and at one month, two months, three months and twelve 
months after randomization. The primary outcome was change in objective adherence to 
recommended CPAP therapy. The total number of hours per night that the CPAP device was used at 
therapeutic pressure was recorded by an on-board counter in each CPAP pump. This data was 
reported by the patients during a phone call at the follow up points, or at the MINT Booster session 
for MINT patients, and the count was confirmed by sleep clinic nurses during standard nurse 
clinics. 
Secondary outcomes were measured using a questionnaire which consisted of sleep-related 
functional and psychological constructs related to the HBM. This questionnaire was administered at 
baseline, one month, and three months after randomization. The questionnaire consisted of; 
The Functional Outcomes of Sleep Questionnaire (FOSQ; scale 5-20; higher scores 
represent greater sleep-related quality of life in OSA (Weaver, Laizner, et al., 1997)). The FOSQ is 
a 30 item measure of the perceived severity construct of the HBM. It directly assesses the 
perception of impact of the disorder on daily functioning. Five domains are assessed, including 
activity level, vigilance, intimacy, general productivity and social outcomes. A mean-centred total 
score representing total functional difficulties related to sleepiness is calculated. Internal 
consistency estimates range from 0.81 to 0.90 for the subscales, and is 0.95 for the total score. 
The Self-Efficacy Measure for Sleep Apnea (SEMSA; scale 1-4; three subscales which 
directly measure three constructs of the HBM: self-efficacy, risk perception and benefits (outcome 
expectancy (Weaver et al., 2003)); higher scores represents more positive CPAP adherence-related 
cognitions). Internal consistencies range from 0.85 to 0.89 and factor analysis confirms the three 
independent subscales. 
The Epworth Sleepiness Scale (ESS; scale 0-24; higher scores represent greater daytime 
sleepiness (Johns, 1991)). It has high internal consistency  and demonstrates good correlations with 
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objective clinical polysomnography (PSG) variables (S. Smith et al., 2008) and measures of sleep 
latency (Miletin & Hanly, 2003). 
In addition to the standard battery outlined above, participants in the MINT group completed 
an additional questionnaire at one month assessing satisfaction with the therapist and treatment: 
The Therapy and Therapist Satisfaction Questionnaire: Revised (TTSQ-R; scale 12-60; 
higher scores indicate greater satisfaction with the therapy and therapist (Oei & Shuttlewood, 
1999)). It is a 12 item questionnaire with items rated on a five point Likert scale (from 1= “strongly 
disagree” to 5= “strongly agree”). It has excellent internal consistency (α = 0.90) and correlates well 
with measures of participation in therapy, progress in therapy, and coping ability. 
As a measure of treatment integrity, two independent raters completed the Behaviour 
Change Counselling Index (BECCI; scale 0-4; higher scores indicate greater demonstration of 
requisite counselling skills (Lane et al., 2005)) in order to assess behaviour change counselling 
skills congruent with the principles of Motivational Interviewing.  Approximately 25% of MINT 
sessions were recorded and rated for treatment integrity using the BECCI. The nurses involved in 
the treatment delivery each recorded a subset of their sessions for integrity checks. A single tape 
recorded was used for this purpose. Each nurse recorded one or two sessions when they had access 
to the tape recorder, and then passed the recorder on to another nurse for them to record one or two 
sessions, and so on. No specific randomisation procedure was implemented. Treatment integrity 
checks through review of the session recordings were conducted at the end of the intervention phase 
of the trial.  
Statistical analysis 
 
The sample size was based on a priori power analysis determining the minimum number of 
participants needed to achieve power to detect the d=.50 between-group effect sizes suggested by 
previous Motivational Intervention research (Burke, et al., 2003). It was estimated that a total 
sample size of 105 participants would provide adequate power (0.80) to detect a difference between 
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the two groups (α=0.05, two tailed) on the primary outcome measure of objective hours of CPAP 
use per night. 
 Hours per night of CPAP use was obtained from the CPAP meter reading at one month post-
treatment initiation (mean days of use= 30.20 days), two months post-treatment initiation (mean 
days of use=60.87), and three months post-treatment initiation (mean days of use=101.14). 
Participants who did not start using CPAP within the three month follow-up period were recorded 
as having a mean adherence of zero. Participants were then contacted at approximately twelve 
months post-treatment initiation for their meter reading (mean days of use=409.39). Again, 
participants who had still not commenced on CPAP were recorded as having a mean adherence of 
zero. 
 
All data analyses were conducted using SPSS for Windows versions 15.0, 17.0 and PASW 
18.0. Pre-treatment differences between the groups were assessed using independent samples t-tests 
and chi-square tests. The primary outcome measure of difference in hours per night use between the 
MINT and control groups at one month, two months, three months and twelve months follow-up, 
was assessed using independent samples t-tests. Change in health beliefs and perceptions on key 
outcome measures as related to the HBM were assessed at time points (Time 1, Time 2 and three 
month follow-up). The outcomes of these measures were compared between the two intervention 
groups using 2 (MINT/control) x 3 (Time 1/Time 2/three month follow-up) mixed design 
ANOVAs. Significant within subjects effects and interaction effects were followed-up using paired-
samples t-tests with Bonferroni correction (use of the p<.01 significance criterion instead of p<.05) 
to guard against type I error (Howell, 2002).  
 
Data Imputation and Screening 
The adherence analyses were by intent-to-treat for participants who meet all inclusion and 
exclusion criteria for the study (n=100). The multiple imputation method for substitution missing 
data from the PASQ 18.0 statistical package was used. All participants had at least two of the 
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adherence data points available (with the exception of one participant in the MINT group). 
Substitution of missing data was not used for the questionnaire data. All univariate and bivariate 
statistical assumptions were met (Tabachnick & Fidell, 2001). Pooled results are reported where 
multiple imputation of missing data was utilised. The Greenhouse-Geisser epsilon was used for 
adjustment of degrees of freedom for analyses when the sphericity assumption was violated.  
 
 
Results 
 
Figure 2 shows the trial profile. 106 participants were randomized and provided baseline 
data between May 2007 and December 2009 (control n=53, MINT n=53). Six participants met 
exclusion criteria after recruitment, thus the final sample consisted of 100 participants (50 in the 
MINT arm, and 50 in the control arm). Table 2 displays the demographic characteristics of the final 
sample of 100 participants meeting inclusion and exclusion criteria. There were no significant 
differences between the MINT group and the control group on key demographic variables, with the 
exception of the MINT group having 1.5 years more education than the control group. All 
questionnaires and resource material were developed with a reading age target of grade seven or 
less, and the education difference was not expected to impact on the interpretability of the findings 
of this study. 
 
Insert Table 2 Here 
 
Insert Figure 2 here 
 
Primary Outcomes: CPAP Acceptance and Adherence 
 
CPAP Acceptance 
 
CPAP acceptance was measured by categorising those who had commenced on CPAP 
within three months, compared to those who had not. Significantly more participants in the MINT 
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group commenced on CPAP after being issued with the script by the three month follow-up point 
(6% rejection rate) as compared to control (28% rejection rate), χ2(1)=8.33, p=.004. By 12 month 
follow-up, the difference between CPAP commencement in the MINT group (4% rejection rate) as 
compared to the control group (26% rejection rate) was still significant, χ2(1)=9.25, p=.002.  
 
CPAP Adherence 
CPAP adherence was measured as the mean number of hours of CPAP use per night (as 
determined by an onboard counter on the CPAP machine) at each of the follow up time points. As 
demonstrated in Table 3, the MINT group used CPAP significantly more hours per night than the 
control group at all of the follow up time points up to three months post treatment initiation. By 
twelve months this difference was marginally not significant. All effect size differences between the 
groups were moderate, except for twelve months which was a small to medium effect. 
Of those participants who commenced on CPAP by three months, the differences between 
the intervention groups failed to reach significance at all follow-up time points (all p>.19), 
indicating that the intervention was most successful in increasing treatment acceptance rates, rather 
than increasing adherence rates post-initiation.  
Table 3 here 
 
Secondary Outcomes: Change in HBM perceptions 
 Mixed design ANOVAs were conducted to determine change in health beliefs and 
subjective sleepiness (ESS) based on membership to the MINT group or control group. Table 4 
displays the statistical values of these analyses.  
Insert Table 4 here 
 
Self-Efficacy 
Overall, the MINT group demonstrated greater self-efficacy than the control group (MINT 
group: mean=3.42; control group: mean=3.11, p=.05).  
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Risk Perception 
 A significant main effect for time emerged for risk perception. Follow-up t-tests revealed 
that there was a reduction in risk perception between Time 1 (mean=2.61) and three month follow-
up (mean=2.42), p=.03, but this difference did not meet the more stringent p<.01 criterion. The 
differences between Time 1 and Time 2 risk (mean=2.54) and between Time 2 risk and three month 
follow-up were also not significant (both p>.05).  
Perception of Severity (FOSQ) 
 For severity perception, a significant main effect for time emerged, such that participants 
indicated better functioning by three month follow-up. Follow-up t-tests revealed that there was a 
significant overall improvement in severity perception (that is, participants reported better 
functioning) between Time 1 (mean=15.09) and Time 2 (mean=16.39), between Time 2 and three 
month follow-up (mean=17.75), and between Time 1 and three month follow-up (all p’s<.01).  
Epworth Sleepiness Score  
 A significant main effect for time emerged for ESS. Follow-up t-tests for the time main 
effect revealed that there was a significant overall reduction in sleepiness between Time 1 
(mean=10.04) and three month follow-up (mean=6.73), p<.01, and between Time 2 (mean=8.90) 
and three month follow-up, p<.01. The difference between Time 1 and Time 2 ESS score, p=.04, 
did not reach the p<.01 statistical significance criterion. 
Social Support 
 
There was no significant difference in adherence for participants in the MINT group who 
had a significant other attend the sessions, as compared to those who did not. This was the case for 
all of the adherence time points (all p’s>.16). 
 
Treatment satisfaction and integrity 
Participants provided a mean total score on the TTSQ-R of 52.95. This equated to a mean 
score of 4.51 out of 5 on the questionnaire rating scale, indicating that participants “agreed to 
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strongly agreed” with the adequacy of the treatment and the therapist in achieving their goals. The 
STTS-R was not correlated with adherence at any of the three follow-up points. 
Across the three sessions the nurses were rated as receiving a mean score on the BECCI 
(Lane, et al., 2005) of between 3.70 and 3.81 out of 4, indicating that the therapists were practicing 
principles of behaviour change counselling to “a great extent”. Consistency between raters for the 
treatment integrity checks was conducted using intra-class correlation coefficients (ICC) for the 
BECCI rating. The inter-rater consistency for these scores was excellent (Session one ICC=0.87; 
Session two ICC=0.99; Session three ICC=0.99). 
 
Discussion 
The MINT intervention was designed to improve CPAP acceptance and adherence in OSA 
sufferers by targeting specific psychological factors identified in a health beliefs model. As 
expected, CPAP acceptance and adherence was higher in participants randomly allocated to MINT, 
as compared to the participants who were allocated to control. Specifically, the participants in 
MINT were six times more likely to commence on CPAP (accept treatment) and used CPAP for 
nearly 50% more hours per night than participants in the control group. The intervention is strong 
particularly in regards to increasing CPAP uptake. CPAP adherence in the MINT group was higher 
overall because many more participants took up CPAP in this group than in the control group. The 
moderate estimated effect-size of the difference in CPAP adherence between the groups is 
consistent with the broader literature of the effectiveness of Motivational interventions in the 
facilitation of treatment adherence (Burke, et al., 2003).  The greater than 25% rejection rates of 
CPAP in the control group are also consistent with the broader CPAP literature (Collard, et al., 
1997; Fletcher & Luckett, 1991). Overall, the MINT participants reported high satisfaction with the 
therapists and the treatment. 
The first MINT session (before the CPAP titration study) targeted the patients’ ambivalence 
to the treatment by increasing their awareness that they had a significant, personally relevant 
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problem (perceived severity from the HBM), and that they were susceptible to negative health 
consequences if they did not use CPAP (perceived risk). In this session, patients were also exposed 
to what CPAP is, and were provided information on the effectiveness of the treatment (perceived 
benefits). The second session presented the pros and cons of the treatment (targeting perceived 
benefits and barriers of CPAP), and the pros and cons of not using CPAP (targeting perceived 
severity, risk and barriers). This session explicitly targeted self-efficacy by development of a 
change plan, which aimed to increase the patients’ belief that they could successfully overcome any 
of the side effects of the treatment, as well as any other difficulties with treatment initiation (such as 
treatment cost). The final session reviewed progress (benefits), reviewed the pros and cons of the 
treatment (benefits and barriers), and refined the change plan (self-efficacy). From time of exposure 
to CPAP, emphasis was placed on the patients’ internally motivated reasons for CPAP acceptance 
and adherence, rather than external motivators (for example, “my physician said I should”). It is 
evident that the MINT intervention is designed to target the explicit components of the HBM 
theorised to be critical in CPAP acceptance and adherence. 
This study demonstrated that intervening very early in the treatment process, beginning 
before CPAP titration, can promote CPAP acceptance, and subsequent acceptance. Given that 
patterns of long term CPAP adherence are usually developed in the first few days to week of CPAP 
use (Aloia, Arnedt, et al., 2007; Aloia, et al., 2005; Budhiraja, Parthasarathy, & Drake, 2007; 
Weaver, Kribbs, et al., 1997), intervening at this early time point is critical. This early intervention 
may explain why the current study demonstrated an improvement in CPAP adherence as compared 
to a control group, while a previous Motivational Enhancement study reported by Aloia, Smith and 
colleagues (2007) did not. Aloia et al. administered the first session of Motivational Enhancement at 
one week after use of CPAP, which may have missed the critical early intervention time point. 
Consistent with this point, Richards and colleagues (2007) delivered a cognitive-behavioural 
intervention (CBT) at similar time points to sessions one and two of the current intervention, and 
found improvements in adherence to CPAP.   
Motivational Intervention improves CPAP adherence 
 20
While the current study demonstrated better outcomes in facilitating CPAP adherence than 
Aloia et al.,’s (2007) Motivational Enhancement study, it demonstrated fairly similar findings to 
Richards and colleagues (2007) recent CBT intervention. Richards et al., found that adherence was 
more than twice as high in the CBT group as compared to the treatment-as-usual group (5.38 hours 
per night versus 2.51 hours per night) by 28 days. However, they only assessed CPAP adherence up 
to 28 days, and their baseline adherence in the treatment-as-usual group was very low (2.5 hours per 
night), while the current study assessed adherence out to twelve months and had a higher baseline 
adherence in the control group (three hours per night).   
There are a few methodological differences between the Richards et al., study and the 
current study that are worthy of note. Firstly, their intervention was delivered by a Psychologist 
trained in Social Cognitive Theory (SCT) and in CBT, which may be considered a particular 
strength of their study. Although the nurses in the current study received a full day training 
workshop, and treatment integrity was assessed and found be adequate, the benefit of a discipline 
specific delivery of the psychological intervention may improve the outcomes of future 
Motivational interventions. MINT training may need to be more in depth than what was achievable 
for the current study. For example, there are intensive training courses provided by world experts in 
Motivational Interviewing available (e.g.: www.motivationalinterview.org). Furthermore, the 
Richards et al., intervention was delivered in a group format. There is some evidence in the CPAP 
adherence intervention literature that CPAP use is facilitated when interventions are delivered in a 
small group format (Golay et al., 2006; Likar, Panciera, Erickson, & Rounds, 1997; Richards, et al., 
2007), and that the use of ‘role models’ who have successfully adjusted to using CPAP in the long-
term is beneficial (Richards, et al., 2007; Wiese et al., 2005). While a strength of the current study 
was the delivery of individualised feedback to the patients in session one, there is the possibility to 
modify MINT such that sessions two and three are delivered in a group format. Thus, potential 
avenues for future research investigating the efficacy of Motivational and psychological 
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interventions in further facilitating CPAP adherence, may be the use of a psychologist, group format 
delivery, and possibly the use of ‘role models’ in supporting longer term adherence. 
Participants assigned to the MINT group reported higher overall self-efficacy than the 
control group. There was no interaction effect, suggesting that self-efficacy did not increase over 
time in the MINT group as opposed the control group. Both groups demonstrated reductions in 
functional severity and lower subjective sleepiness by three months, although these changes cannot 
be attributed to the intervention. The intervention encouraged participation of a ‘significant other’ 
based on social support literature (Baron et al., 2009; Billman & Ware, 2002; Parish & Lyng, 2003), 
but the presence of a significant other was not found to be a critical treatment component.  
The current study overcame specific limitations of previous CPAP adherence intervention 
studies, by recruiting an adequate sample size determined by a priori power analysis, by randomly 
allocating patients to the intervention arms, by use of intent-to-treat analyses, and by explicitly 
testing the change in health beliefs pre- and post-intervention and at three month follow-up. 
Assessment of the primary adherence outcomes up to twelve months follow-up is a significant time 
period compared to many of the previous studies in this area (Olsen, Smith, & Oei, 2008).  
Unfortunately the difference in CPAP adherence between the intervention groups at 12 
months follow-up was marginally not significant. This is likely due to the study being slightly 
underpowered to detect this difference (a priori power analysis suggested a sample size of 105 was 
required, but only 100 was achieved after exclusions). Regardless, this effect is marginal and 
strongly suggests that a motivational booster is required at approximately this time to further 
reinforce, or to increase motivation to continue to adhere to CPAP. 
The current study was underpowered to assess in appropriate depth the changes to health 
belief perceptions in the MINT group relative to the control group. We have published theoretical 
and research papers in this area, and have argued strongly for the need for multivariate structural 
equation modelling methodology for appropriate elucidation of this model (Olsen, Smith, & Oei, 
2008; Olsen, Smith, Oei, et al., 2008). Our aim in future research is to assess in depth processes of 
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change underlying improvements in CPAP acceptance and adherence in relation to changes in 
health beliefs perceptions. The methods used to statistically assess changes in health beliefs 
perceptions in the current study were appropriate given the power available to assess these change, 
but it is likely that these univariate methods were did not take adequately into account the 
complexity of the psychological processes driving change in the MINT group.  
A limitation of the study was that the intervention was not time-matched to the control arm, 
but rather was provided as an addition to the standard care that all patients already received. It is 
unlikely that non-specific benefit due to additional therapist time provides a full explanation for the 
observed differences. However the fact that the MINT group demonstrated higher overall self-
efficacy than the control group, but that this variable did not significantly increase in the MINT 
group over time relative to the control group, suggests that there may have been something about 
the implicit knowledge of group membership, and additional therapist time, that increased self-
efficacy overall in MINT relative to control participants. Patients and therapists were not blinded to 
the assigned intervention group. Although it was not made explicit to patients that the MINT group 
was expected to use CPAP more hours per night, it is possible that this expectation was implied by 
way of their assignment to the ‘intervention’ group. Blinding is difficult to achieve in social and 
behavioural intervention studies, and double-blind studies are near to impossible to achieve. 
However, the use of a time-matched placebo intervention study in future studies, and attempts to 
blind patients to ‘effective’ group membership, is a worthy goal. 
Participants in the MINT group reported higher education levels. This is not expected to 
have influenced the results as education level is not a consistent correlate of CPAP adherence. Race 
and gender were not considered, and should be controlled for in future research given some data in 
the literature indicating that these factors may play a role in CPAP adherence (Olsen, Smith, & Oei, 
2008). One psychological variable which could have been considered either for outcome 
measurement, or for assessment of equality of groups at baseline, is ‘coping’ perception. Previous 
research has found that an individual’s tendency towards active or passive coping impacts on CPAP 
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adherence. Specifically, patients who use ‘active’ ways of coping with life situations before starting 
treatment use CPAP more at follow-up. ‘Active’ coping refers to a tendency to use active means to 
manage difficult situations (Stepnowsky, Bardwell, Moore, Ancoli-Israel, & Dimsdale, 2002).  
 An important direction for future research is to consider patient need in delivery of 
motivational interventions. This would require determining which patients are likely to benefit from 
the intervention should they be referred for the additional support. In essence, future work will need 
to investigate who is likely to benefit from MINT, who is not, and if not, why not. It is quite 
possible that a subset of the patients assigned to MINT would have succeeded with CPAP anyway. 
Similarly, it is likely that a subset of patients did not accept or adhere to CPAP even with the 
intervention. A clear direction for CPAP intervention research then, is to define the mechanisms by 
which patients should flow through the OSA diagnosis and treatment pathways in order to 
maximally support treatment success. For example, there may be a range of interventions available, 
from simple education upwards, depending on patient need.  
In summary, the MINT Intervention for CPAP adherence is a brief, manualized, and 
effective intervention which improves CPAP acceptance and adherence rates as compared to 
standard care alone. A key implication of this study is the importance of delivery of the intervention 
early in the treatment exposure and initiation phases.  
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TABLES 
 
Table 1: Motivational Intervention Session content and targets. 
Session 1 
Building Motivation for Change 
Session 2
Strengthening Commitment to 
Change 
Session 3 
Booster Session 
 Commence Intervention 
 Explore motivation to treat sleep 
problem and begin to elicit 
discrepancy between ideal and 
current functioning 
 Elicit self-motivational statements 
 Summarise Themes of Concern 
and motivational statements 
 Present Personalised Feedback 
 ‘Sleep Characteristics’ 
 ‘Current Functioning’ 
 ‘Functional Outcomes of 
Sleep’ 
 ‘Satisfaction with Life’ 
 ‘Sleep Health Statistics’ 
 ‘Other Health Concerns’ 
 Discuss importance of treatment 
 Present CPAP as the 
recommended treatment  
 Emphasise free choice 
 Summarise  
 Summary of Session 1
 Review themes of concern 
 Complete decisional 
balance worksheet 
 Summarise pros and cons 
of treatment 
 Summarise pros and cons 
of not using CPAP 
 Discuss realistic 
expectations in key areas of 
concern with CPAP use 
 Complete change plan 
worksheet 
 Generate explicit goal for 
CPAP use (e.g. “all night, 
every night”) 
 Assess commitment to 
change 
 Summarise 
 
 
 Summary of Sessions 1 and 2
 Review of patient progress with 
CPAP commencement 
 Reinforce attempts at change 
 Review decisional balance 
worksheet 
 Identify areas of observed 
improvement with CPAP 
 Discuss additional areas of 
expected change with continued 
use 
 Identify key barriers to CPAP 
use 
 Review change plan worksheet 
 Make changes to plan in light 
of new experiences 
 Review goal for CPAP use 
 Assess commitment to change 
 Summarise 
 Terminate Intervention 
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Table 2. Demographic characteristics of the participant samples. 
 
 
 
 
 
 
MINT Group 
(n=50) 
Mean (+SD) 
Control 
Group (n=50) 
Mean (+SD) 
Gender 31 male, 19 female 38 male, 12 female
Age, years 55.14 (12.58) 57.74 (9.51) 
Respiratory Disturbance Index (RDI) 
events/hr 
36.23 (27.76) 32.39 (20.32) 
Body Mass Index (BMI), kg/m2 34.28 (6.71) 34.65 (7.07) 
CPAP pressure,  cmH2O 10.73 (2.81) 11.23 (2.59) 
Epworth Sleepiness Score (ESS)  10.82 (4.41) 11.14 (5.32) 
Years of education 12.02 (3.41) 10.59 (2.42) * 
Relationship status  
      Married 
      De facto relationship 
      Relationship not living together 
      Single 
(% of sample)
63.27 
  6.12 
  2.04 
28.57 
(% of sample) 
70.83 
  4.17 
  4.17 
22.83 
* p=0.015 
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Table 3: Adherence differences between MINT and Control groups. 
         Mean treatment    
      adherence (+ SD) 
   p value       
 
           
Effect Size (cohen’s d)
 
 MINT Control           
Adherence (hrs/night) 
One month     
4.85 (2.55) 3.25 (2.83)             0.003 0.59  
Adherence (hrs/night) 
Two months 
4.73 (2.62) 3.22 (2.76)              0.005 0.56 
Adherence (hrs/night) 
Three months 
4.63 (2.69) 3.16 (2.69)             0.005 0.55 
Adherence (hrs/night) 
Twelve months 
4.21 (3.25) 3.00 (3.18)             0.061 0.38 
Note: All values are pooled results from multiple imputation analyses 
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Table 4: Main effects summary for the Time and Group mixed design ANOVAs. 
 
                                                                    Main Effects Interaction 
OUTCOME 
MEASURE 
   Group       
Time 1  
(Baseline) 
Mean (+ SD) 
Time 2 
(one month) 
Mean (+ SD) 
3 month f/up
 
Mean (+ SD) 
 
Time point 
 
 
            Group 
 
 
Group x Time point 
SELF-EFFICACY    
(possible range=1-4) 
   MINT 
 
 
3.38 (0.48) 
 
 
3.45 (0.48) 
 
 
 
3.42 (0.46) 
 
 
F(1.65,61.19)1=0.36, p=.66 
 
 
F(1, 37)=4.04*pη2=.10 
 
 
F(2, 74)=0.20, p=.82 
   Control 3.07 (0.63) 3.10 (0.74) 3.17 (0.55) 
 
 
   
RISK   (range=1-4) 
    MINT 
 
2.58 (0.58) 
 
 
2.56 (0.73) 
 
2.37 (0.73) 
 
 
F(2, 74)=3.54* pη2=.09
 
 
F(1, 37)=0.05, p=.82
 
 
F(2, 74)=0.45, p=.64 
   Control 2.65 (0.62) 2.52 (0.63) 2.47 (0.67)    
SEVERITY (range=5-20)
   MINT 
 
15.15 (3.36) 
 
16.94 (2.91) 
 
17.78 (2.61) 
 
 
F(2,74)=17.55** pη2=.32
 
 
F(1, 37)=0.31, p=.58
 
 
F(2, 74)=0.86, p=.43 
   Control 15.04 (3.12) 15.84 (2.85) 17.71 (2.15)    
BENEFITS  (range=1-4)
    MINT 
 
3.10 (0.51) 
 
3.19 (0.59) 
 
3.07 (0.66) 
 
 
F(1.70,62.81)1=0.73, p=.49
 
 
F(1, 37)=2.03, p=.16
 
 
F(2, 74)=0.99, p=.38 
   Control 2.98 (0.74) 2.83 (0.55) 2.81 (0.64)    
ESS  (range=0-24) 
  MINT 
 
10.48 (3.41) 
 
8.26 (4.00) 
 
6.00 (3.16) 
 
 
F(2,72)11.58* pη2=.24
 
 
F(1, 36)=0.37, p=.55
 
 
F(2, 72)=1.74, p=.18 
   Control 9.60 (4.14) 9.53 (5.18) 7.47 (3.83)    
 1Greenhouse-Geisser correction     *p<0.05      **p<0.01
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Note: possible score ranges are represented in parenthesis.
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 Adherence assessed 
 
 
Figure 1: Timeline representing Control, MINT and Questionnaire completion. 
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Error! Reference source not found. 
 
Figure 2: CONSORT diagram of the participant flow through the trial.   
 
Assessed for eligibility (n =132) 
 Not meeting inclusion criteria (n= 3) 
3 patients with signs of cognitive decline. 
1 also with co-morbid severe depressive illness. 
 Declined to participate (n= 23) (18%) 
Primary Reported Reasons: 
Time constraints; living outside of health 
district; “I don’t think I need it” (I already want 
to succeed with CPAP). 
